Lansopram

Lansoprazole, the active ingredient in Lansopram, is a proton pump inhibitor presented as a tablet for oral use. It treats acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, peptic ulcer disease and is used in Helicobacter pylori eradication regimens. Lansopram helps reduce gastric acid production and promotes healing of the gastrointestinal lining.

GNH USA supplies Lansopram as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansopram, a proton pump inhibitor, is employed in the management of acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease: reduces reflux symptoms and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates healing of erosive lesions in the esophagus. - Peptic ulcer disease: facilitates ulcer healing and helps prevent recurrence. - Helicobacter pylori eradication: used as part of combination therapy to eradicate H. pylori infection.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of unease or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhea with possible colitis. - Interstitial nephritis: inflammation of kidney tissue. - Low magnesium levels: muscle cramps, weakness, or irregular heartbeat.

Before initiating Lansopram, consider the following precautions: - Renal function assessment: adjust use in patients with impaired kidney function. - Monitor for infections: be alert to signs of gastrointestinal infections. - Evaluate magnesium status: prolonged therapy may deplete magnesium. - Use cautiously in the elderly: higher risk of adverse effects. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansopram may interact with several medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption due to increased gastric pH. - Atazanavir: decreased antiviral effectiveness. - Iron supplements: impaired iron absorption.

Moderate Interactions (Monitor Closely): - Clopidogrel: possible reduction in antiplatelet activity. - Digoxin: increased serum digoxin levels. - Methotrexate: higher risk of toxicity. - Phenytoin: altered plasma concentrations.